BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8502705)

  • 1. Prolonged alpha interferon therapy for chronic delta hepatitis: effect on liver histopathology.
    Kleiner D; Di Bisceglie AM; Axiotis CA; Hoofnagle JH
    Prog Clin Biol Res; 1993; 382():365-71. PubMed ID: 8502705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy of chronic delta hepatitis with alpha- and beta-interferon.
    Gaudin JL; Trépo C
    Prog Clin Biol Res; 1993; 382():345-52. PubMed ID: 8502701
    [No Abstract]   [Full Text] [Related]  

  • 3. Alpha 2 recombinant interferon in the treatment of chronic hepatitis delta virus (HDV) hepatitis.
    Rosina F; Saracco G; Lattore V; Quartarone V; Rizzetto M; Verme G; Trinchero P; Sansalvadore F; Smedile A
    Prog Clin Biol Res; 1987; 234():299-303. PubMed ID: 3628384
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of early chronic delta hepatitis with lymphoblastoid alpha interferon: a pilot study.
    Marzano A; Ottobrelli A; Spezia C; Daziano E; Soranzo ML; Rizzetto M
    Ital J Gastroenterol; 1992; 24(3):119-21. PubMed ID: 1562748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of hepatitis delta virus (HDV) replication by lymphoblastoid human alpha interferon.
    Thomas HC; Farci P; Shein R; Karayiannis P; Smedile A; Caruso L; Gerin J
    Prog Clin Biol Res; 1987; 234():277-90. PubMed ID: 3628382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Italian trials of interferon alpha in chronic delta hepatitis.
    Rosina F; Saracco G; Cozzolongo R; Costa C; Bonino F; Verme G; Rizzetto M
    Prog Clin Biol Res; 1993; 382():353-8. PubMed ID: 8502703
    [No Abstract]   [Full Text] [Related]  

  • 7. Serological diagnosis of chronic delta infection: correlation between serological markers and hepatitis delta virus RNA in hepatic tissue.
    Buti M; Lopez-Talavera JC; Allende H; Jardi R; Esteban R; Guardia J
    Prog Clin Biol Res; 1993; 382():319-23. PubMed ID: 8502697
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment with recombinant alpha 2b-interferon of chronic HDV hepatitis in children.
    Craxì A; Di Marco V; Volpes R; Marra S; Rizzetto M; Rosina F; Barbera C; Bortolotti F; Crivellaro C; Iannuzzi C
    Prog Clin Biol Res; 1991; 364():399-404. PubMed ID: 2020715
    [No Abstract]   [Full Text] [Related]  

  • 9. Elimination of hepatitis delta virus infection after loss of hepatitis B surface antigen in patients with chronic delta hepatitis.
    Battegay M; Simpson LH; Hoofnagle JH; Sallie R; Di Bisceglie AM
    J Med Virol; 1994 Dec; 44(4):389-92. PubMed ID: 7897369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis D virus infection in liver tissues of patients with hepatitis B in China.
    Hao LJ; Li L; Zhang YY; Song PH
    Chin Med J (Engl); 1992 Mar; 105(3):204-8. PubMed ID: 1395839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha lymphoblastoid interferon and acyclovir for chronic hepatitis delta.
    Berk L; de Man RA; Housset C; Berthelot P; Schalm SW
    Prog Clin Biol Res; 1991; 364():411-20. PubMed ID: 2020718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial of a 12-month course of recombinant human interferon-alpha in chronic delta (type D) hepatitis: a multicenter Italian study.
    Rosina F; Pintus C; Meschievitz C; Rizzetto M
    Hepatology; 1991 Jun; 13(6):1052-6. PubMed ID: 2050321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha interferon therapy of chronic delta hepatitis: a pilot study.
    Di Bisceglie AM; Negro F; Smedile A; Bergmann K; Hoofnagle JH
    Prog Clin Biol Res; 1991; 364():393-7. PubMed ID: 2020714
    [No Abstract]   [Full Text] [Related]  

  • 14. Significance of IgM anti-hepatitis D virus (HDV) in chronic HDV infection.
    Lau JY; Smith HM; Chaggar K; Hansen LJ; Portmann BC; Alexander GJ; Williams R
    J Med Virol; 1991 Apr; 33(4):273-6. PubMed ID: 1856706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis delta superinfection during alpha-interferon treatment for hepatitis B.
    Craxì A; Di Marco V; Bruno R; Fabiano C
    Ital J Gastroenterol; 1992 Jan; 24(1):19-20; discussion 20-1. PubMed ID: 1571575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum immunoglobulin M antibody to hepatitis D as a surrogate marker of hepatitis D in interferon-treated patients and in patients who underwent liver transplantation.
    Borghesio E; Rosina F; Smedile A; Lagget M; Niro MG; Marinucci G; Rizzetto M
    Hepatology; 1998 Mar; 27(3):873-6. PubMed ID: 9500721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of chronic delta infection with recombinant human interferon alpha 2c at high doses.
    Porres JC; Carreño V; Bartolomé J; Moreno A; Galiana F; Quiroga JA
    J Hepatol; 1989 Nov; 9(3):338-44. PubMed ID: 2691569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic hepatitis delta virus (HDV) infection.
    Gerken G; Meyer zum Büschenfelde KH
    Hepatogastroenterology; 1991 Feb; 38(1):29-32. PubMed ID: 2026385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The intrahepatic expression of the hepatitis B virus in chronic delta hepatitis].
    Ramalho F; Velosa J; Costa A; Baptista A; de Moura MC
    Acta Med Port; 1993 May; 6(5):187-91. PubMed ID: 8337951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The French experience of treatment of chronic type D hepatitis with a 12-month course of interferon alpha-2B. Results of a randomized controlled trial.
    Gaudin JL; Faure P; Godinot H; Gerard F; Trepo C
    Liver; 1995 Feb; 15(1):45-52. PubMed ID: 7776857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.